# A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder

> **NCT00593099** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 5 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Bupropion
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00593099
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2017-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00593099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00593099, "A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00593099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*